A potential takeover is being explored by OpenEvidence after a recent injection of new capital. The AI search engine for physicians secured $250 million in funding, which pushed its market valuation to $15 billion, up from $12 billion in January.

The company provides medical professionals with specialized AI tools to search and synthesize clinical information. The decision to consider a sale follows a political backlash against artificial intelligence that has shifted the startup's strategic outlook.